Increased activity of nuclear factor-κB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats

Circulation

Volumn 102, Issue 7, 2000, Pages 806-812

  Kitamoto, Shiro ^a   Egashira, Kensuke ^a   Kataoka, Chu ^a   Koyanagi, Masamichi ^a   Katoh, Makoto ^c   Shimokawa, Hiroaki ^a   Morishita, Ryuichi ^b   Kaneda, Yasufumi ^b   Sueishi, Katsuo ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Tanabe Sei Yaku Co Ltd   (Japan)

Author keywords

Cells; Endothelium derived factors; Inflammation; Nitric oxide; Nuclear factor B; Proteins

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR INFLAMMATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; MALE; MEDIATOR RELEASE; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

EID: 0033894949     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.7.806     Document Type: Article

References (31)

1. Atherosclerosis: An inflammatory disease
2. Cellular and molecular mechanisms of endothelial cell dysfunction
3. Endothelial control of the cardiovascular system: Recent advances
4. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
5. Nitric oxide regulates monocyte chemotactic protein-1
6. Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultural human endothelial cells
7. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
8. Nitric oxide decreases cytokine-induced endothelial activation nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
9. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice
10. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling
11. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats
12. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade
13. Cardiac angiotensin II receptor is upregulated by long-term inhibition of nitric oxide synthesis in rats
14. Inhibition of nitric oxide synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels
15. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
16. Chronic inhibition of nitric oxide synthesis causes pathologic coronary microvascular remodeling and myocardial fibrosis
17. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
18. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers
19. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells
20. Oxygen radical as second messenger for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G
21. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
22. Chemokines
23. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion
24. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
25. Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats
26. Application of transcription factor 'decoy' strategy as means of gene therapy and study of gene expression in cardiovascular disease
27. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction
28. Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1
29. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-I gene
30. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells
31. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation